A detailed history of Regentatlantic Capital LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Regentatlantic Capital LLC holds 7,535 shares of DGX stock, worth $1.03 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,535
Previous 7,532 0.04%
Holding current value
$1.03 Million
Previous $1 Million 7.78%
% of portfolio
0.03%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$121.77 - $141.1 $365 - $423
3 Added 0.04%
7,535 $924,000
Q2 2022

Aug 15, 2022

SELL
$127.07 - $145.39 $35,833 - $40,999
-282 Reduced 3.61%
7,532 $1 Million
Q1 2022

May 02, 2022

BUY
$129.09 - $164.35 $32,401 - $41,251
251 Added 3.32%
7,814 $1.07 Million
Q4 2021

Jan 27, 2022

SELL
$140.36 - $173.01 $3,509 - $4,325
-25 Reduced 0.33%
7,563 $1.31 Million
Q3 2021

Nov 15, 2021

BUY
$132.95 - $158.0 $14,624 - $17,380
110 Added 1.47%
7,588 $1.1 Million
Q2 2021

Aug 12, 2021

BUY
$126.66 - $141.48 $12,539 - $14,006
99 Added 1.34%
7,478 $987,000
Q1 2021

Apr 29, 2021

SELL
$114.63 - $133.34 $126,895 - $147,607
-1,107 Reduced 13.05%
7,379 $947,000
Q4 2020

Feb 04, 2021

BUY
$112.7 - $128.05 $15,327 - $17,414
136 Added 1.63%
8,486 $1.01 Million
Q3 2020

Oct 13, 2020

BUY
$107.05 - $130.01 $26,762 - $32,502
250 Added 3.09%
8,350 $956,000
Q2 2020

Aug 13, 2020

BUY
$73.34 - $122.61 $30,582 - $51,128
417 Added 5.43%
8,100 $923,000
Q1 2020

May 14, 2020

BUY
$75.14 - $115.68 $1,127 - $1,735
15 Added 0.2%
7,683 $617,000
Q4 2019

Feb 04, 2020

SELL
$100.29 - $107.99 $49,844 - $53,671
-497 Reduced 6.09%
7,668 $819,000
Q3 2019

Oct 22, 2019

SELL
$97.85 - $107.42 $10,176 - $11,171
-104 Reduced 1.26%
8,165 $874,000
Q2 2019

Jul 23, 2019

SELL
$85.18 - $101.94 $8,347 - $9,990
-98 Reduced 1.17%
8,269 $842,000
Q1 2019

May 03, 2019

SELL
$80.68 - $89.92 $3,953 - $4,406
-49 Reduced 0.58%
8,367 $752,000
Q4 2018

Jan 30, 2019

BUY
$79.75 - $108.38 $4,067 - $5,527
51 Added 0.61%
8,416 $701,000
Q3 2018

Oct 30, 2018

SELL
$105.42 - $114.99 $8,328 - $9,084
-79 Reduced 0.94%
8,365 $903,000
Q2 2018

Jul 31, 2018

SELL
$97.35 - $113.14 $12,655 - $14,708
-130 Reduced 1.52%
8,444 $928,000
Q1 2018

Apr 23, 2018

SELL
$96.42 - $107.88 $25,069 - $28,048
-260 Reduced 2.94%
8,574 $860,000
Q4 2017

Jan 23, 2018

SELL
$90.86 - $100.24 $23,714 - $26,162
-261 Reduced 2.87%
8,834 $870,000
Q3 2017

Oct 25, 2017

BUY
$91.96 - $108.35 $836,376 - $985,443
9,095
9,095 $852,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.